Industry Segments (Tables) |
3 Months Ended |
|---|---|
Dec. 31, 2021 | |
| Industry Segments [Abstract] | |
| Schedule of Segment Reporting Information | Three Months Ended December 31, 2021 2020 FC2*$ 10,858,751 $ 9,914,936Pharmaceuticals (11,648,249) (5,858,837)Corporate (4,172,787) 15,131,058Operating (loss) income$ (4,962,285) $ 19,187,157 |
| X | ||||||||||
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|